Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
Aging · 2023
DOI: 10.18632/aging.205181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Shuaishuai Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Ningbo Urology and Nephrology Hospital, Ningbo, China. Hauptthemen laut MEDLINE: Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Apoptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory, Ningbo Urology and Nephrology Hospital, Ningbo, China.
- Department of Emergency, Ningbo Urology and Nephrology Hospital, Ningbo, China.
- Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ultrasound, Ningbo Urology and Nephrology Hospital, Ningbo, China.
Zitieren
APA
Huang, S., Cai, C., Zhou, K., Wang, X., Wang, X., Cen, D., & Weng, G. (2023). Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging. https://doi.org/10.18632/aging.205181
Vancouver
Huang S, Cai C, Zhou K, Wang X, Wang X, Cen D, et al. Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging. 2023. doi:10.18632/aging.205181
BibTeX
@article{Huang2023,
author = {Huang, Shuaishuai and Cai, Congbo and Zhou, Kena and Wang, Xue and Wang, Xue and Cen, Dong and Weng, Guobin},
title = {Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205181}
}
EUVIMED